Dermapharm Holding SE annual total assets
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Dermapharm Holding SE Total Assets Growth & History (DMP)
Dermapharm Holding SE's total assets was €2.19B for fiscal 2025.
View full Dermapharm Holding SE company overviewDermapharm Holding SE annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | €2.19B | €106.8M | +5.13% |
| 2024 | 2024-12-31 | €2.08B | −€80.7M | −3.73% |
| 2023 | 2023-12-31 | €2.16B | €747.8M | +52.93% |
| 2022 | 2022-12-31 | €1.41B | €5.9M | +0.42% |
| 2021 | 2021-12-31 | €1.41B | €182.6M | +14.91% |
| 2020 | 2020-12-31 | €1.22B | €179.5M | +17.18% |
| 2019 | 2019-12-31 | €1.04B | €340.3M | +48.30% |
| 2018 | 2018-12-31 | €704.6M | €289.3M | +69.66% |
| 2017 | 2017-12-31 | €415.3M | €103.6M | +33.24% |
| 2016 | 2016-12-31 | €311.7M | €15.0M | +5.07% |
| 2015 | 2015-12-31 | €296.7M | −€33.9M | −10.26% |
| 2014 | 2014-12-31 | €330.6M | — | — |
Dermapharm Holding SE quarterly total assets
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | €2.24B | €106.8M | +5.00% |
| Q1 2026 | 2026-03-31 | €2.27B | €160.9M | +7.62% |
| Q4 2025 | 2025-12-31 | €2.19B | — | — |
| Q3 2025 | 2025-09-30 | €2.12B | — | — |
| Q2 2025 | 2025-06-30 | €2.14B | — | — |
| Q1 2025 | 2025-03-31 | €2.11B | — | — |
Dermapharm Holding SE total assets trends
Over the last five fiscal years, Dermapharm Holding SE's total assets increased from €1.22B to €2.19B, a change of €962.4M. The latest reported quarter, Q2 2026, shows €2.24B.
About the metric
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
Calculation and source
reported total assets
TickerStat uses total assets reported in company official filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Dermapharm Holding SE source filings ↗